Treatment of Oral Candidiasis Complicated by Diabetes, Steroid Use, or an Immunocompromised State
When oral candidiasis occurs alongside diabetes, corticosteroid use, or an immunocompromised condition — or when tooth decay is an additional concern — standard topical preparations may not be appropriate, and systemic therapy is typically required.
This protocol is for oral candidiasis where tooth decay is a concern, or where the infection is complicated by diabetes, steroid use, or an immunocompromised state. The sucrose content of certain topical agents is a clinically relevant factor in these patients, making systemic triazole therapy the preferred route.
When a first-line triazole has not been adequate — particularly in immunocompromised patients — a broader-spectrum triazole agent is considered for salvage. Full criteria, sequencing, and regimen details are available in the structured protocol below.
References
DOI: 10.1136/pmj.78.922.455
Both nystatin oral rinses and clotrimazole troches have a high sucrose content and if tooth decay is a concern or the oral candidiasis is complicated by diabetes, steroid use or an immunocompromised state, triazoles which include fluconazole or itraconazole once per day has been found to be effective in these cases.
Itraconazole has a wider spectrum of activity than fluconazole and is therefore valuable in salvage treatment of the immunocompromised patients with fluconazole resistant candidosis.
View source ↗